Concepedia

Ruby Cai

RC

10

Publications

542

Citations

10

H-Index

2003

Active since

Affiliations

Gilead Sciences (United States)(Current)

Ruby Cai is an author at Gilead Sciences (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2003–2021

10

Publications

10

Inhibition of Respiratory Syncytial Virus Fusion by the Small Molecule VP-14637 via Specific Interactions with F Protein

Janet L. Douglas, Marites L. Panis, Edmund Ho et al. · Journal of Virology · 2003 · 119 citations · Full text

Small Molecules VP-14637 and JNJ-2408068 Inhibit Respiratory Syncytial Virus Fusion by Similar Mechanisms

Janet L. Douglas, Marites L. Panis, Edmund Ho et al. · Antimicrobial Agents and Chemotherapy · 2005 · 99 citations · Full text

Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle

Richard L. Mackman, Victoria A. Steadman, David K. Dean et al. · Journal of Medicinal Chemistry · 2018 · 75 citations · Full text

Discovery of GS-9256: A novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity

X. Christopher Sheng, Anthony Casarez, Ruby Cai et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 48 citations

, , +10

Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease

X. Christopher Sheng, T.C. Appleby, Thomas Butler et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 42 citations · Full text

, , +8

Rows per page

1–5 of 10